Anastasia Hughes

ORCID: 0009-0003-5512-0333
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Dialysis and Renal Disease Management
  • Childhood Cancer Survivors' Quality of Life
  • Hematopoietic Stem Cell Transplantation
  • Mesenchymal stem cell research
  • Mental Health and Patient Involvement
  • Adolescent and Pediatric Healthcare
  • Patient-Provider Communication in Healthcare
  • Geriatric Care and Nursing Homes
  • Renal Transplantation Outcomes and Treatments
  • Health Policy Implementation Science
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Single-cell and spatial transcriptomics
  • MicroRNA in disease regulation
  • Epigenetics and DNA Methylation
  • Cancer Cells and Metastasis
  • Poisoning and overdose treatments
  • Chronic Disease Management Strategies
  • Delphi Technique in Research
  • Gender, Feminism, and Media
  • Neonatal Respiratory Health Research
  • Histone Deacetylase Inhibitors Research

The University of Sydney
2024-2025

Children's Hospital at Westmead
2024-2025

Curtin University
2021-2025

University of Bari Aldo Moro
2025

Sydney Local Health District
2024

The Kids Research Institute Australia
2018-2024

The University of Melbourne
2023

The University of Western Australia
2018-2021

Abstract Infants with KMT2A -rearranged B-cell acute lymphoblastic leukemia (ALL) have a dismal prognosis. Survival outcomes remained static in recent decades despite treatment intensification and novel therapies are urgently required. infant ALL cells characterized by an abundance of promoter hypermethylation exhibit high BCL-2 expression, highlighting potential for therapeutic targeting. Here, we show that hypomethylating agents vitro additivity when combined most conventional...

10.1038/s41375-022-01746-3 article EN cc-by Leukemia 2022-11-15
D. Coghlan Allison Tong Anastasia Hughes Rebecca Wu Andrea K. Viecelli and 95 more Noa Amir Hayley Candler Brydee Cashmore Yeoungjee Cho Jonathan C. Craig Rosanna Cazzolli Chandana Guha Carmel M. Hawley Amandi Hiyare-Hewage Martin Howell Shilpanjali Jesudason David W Johnson Dominic Keuskamp Feruza Kholmurodova Karine Manera Jasmin Mazis Stephen McDonald Shyamsundar Muthuramalingam Javier Recabarren Silva Amanda Sluiter Armando Teixeira-Pinto David J. Tunnicliffe Anita van Zwieten Pushparaj Velayudham Germaine Wong Nicole Scholes‐Robertson Adela Yip Alice Kennard Allan Blackley Allison Jaure Amanda Dominello Amanda Sluiter Amandi Hiyare Amber Williamson Amy Luchterhand Anastasia Hughes Andrea Viecelli Adam Currey Angela Rejuso Anh Kieu Allen Y. Tien Anita van Zwieten Annie Conway Armando Teixeira‐Pinto Bill Bill Breonny Robson Benjamin C. Johnson Carmel Hawley Chandana Guha Clarissa Hompas D. Coghlan Darling Rojas-Canales David J. Tunnicliffe Dominic Keuskamp Effie Johns Erandi Hewawasam Francis E. Lord Francesca A. Carlisle Fleur Tuthill Germaine Wong Gorjana Radisic Hayley Candler Heather L. Shepherd Helen Coolican Henry Pleass Ieyesha Roberts Irene Mewburn Isabelle Haklar Janelle Colquhoun Janet Kelly Jasmin Mazis Javier Recabarren Jill Brown J. K. A. Roberts Karine Manera Kathy Strudwick Kim‐Huong Nguyen Luca G. Torrisi M. C. Parker Madeleine Rapisardi Martin Howell Michael Collins Natalie Brown Nicky Boulter Nicole Scholes‐Robertson Noa Amir Pushparaj Velayudham Rachel Li Richard K. Le Leu R Rapanà Robert Dale Rosanna Cazzolli S. Jahn Sally E. Spence Seethalakshmi Viswanathan

10.1093/ckj/sfaf021 article EN cc-by-nc Clinical Kidney Journal 2025-01-24

Abstract Rationale & Objective Children and adolescents with chronic kidney disease (CKD) are at risk of depression other mental health conditions, which can impair quality life, the capacity for self-management adherence to treatment, overall health. This study aimed describe perspectives patients caregivers on in children across all stages CKD. Study Design Qualitative study. Settings Participants A secondary analysis a consensus, multi-stage inclusive process designed establish core...

10.1093/ckj/sfaf067 article EN cc-by-nc Clinical Kidney Journal 2025-03-08

The microenvironments of leukemia and cancer are critical for multiple stages malignancies, they an attractive therapeutic target. While skeletal abnormalities commonly seen in children with acute lymphoblastic (ALL) prior to initiating osteotoxic therapy, little is known about the alterations bone marrow microenvironment during leukemogenesis. Therefore, this study, we focused on development precursor-B cell ALL (pre-B ALL) immunocompetent BCR-ABL1+ model. Here show that hematopoiesis was...

10.1038/s41375-018-0144-7 article EN cc-by Leukemia 2018-04-27

Abstract The bone marrow microenvironment (BMM) plays a key role in leukemia progression, but its molecular complexity pre-B cell acute lymphoblastic (B-ALL), the most common cancer children, remains poorly understood. To gain further insight, we used single-cell RNA sequencing to characterize kinetics of murine BMM during B-ALL progression. Normal pro- and cells were found be affected at earliest stages disease this was associated with changes expression genes regulated by AP1-transcription...

10.1038/s41598-020-76157-4 article EN cc-by Scientific Reports 2020-11-05

Background Infants with KMT2A -rearranged B-cell precursor acute lymphoblastic leukemia (ALL) have poor outcomes. There is an urgent need to identify novel agents improve survival. Proteasome inhibition has emerged as a promising therapeutic strategy for several hematological malignancies. The aim of this study was determine the preclinical efficacy selective proteasome inhibitor carfilzomib, infants ALL. Methods Eight infant ALL cell lines were extensively characterized immunophenotypic and...

10.3389/fonc.2021.631594 article EN cc-by Frontiers in Oncology 2021-04-15

Abstract In response to rapid and substantial increases in rates of e-cigarette use among young people, Australia’s Therapeutic Goods Administration (TGA) made changes the regulations governing nicotine vaping products. As part regulatory change process, Australians were invited comment on proposed regulations, which featured introduction a prescription model for To inform strategies enhance compliance with tightened this study examined submissions by self-reported users TGA’s public...

10.1093/heapro/daad080 article EN cc-by-nc-nd Health Promotion International 2023-08-01

Components of the bone marrow microenvironment (BMM) have been shown to mediate way in which leukemia develops, progresses and responds treatment. Increasing evidence shows that leukemic cells hijack BMM, altering its functioning establishing leukemia-supportive interactions with stromal immune cells. While previous work has highlighted functional defects mesenchymal stem cell (MSC) population from BMM acute leukemias, thorough characterization molecular profiling MSCs pre-B lymphoblastic...

10.3389/fcell.2023.1005494 article EN cc-by Frontiers in Cell and Developmental Biology 2023-01-20

Abstract The rarity of the mesenchymal stem cell (MSC) population poses a significant challenge for MSC research. Therefore, these cells are often expanded in vitro, prior to use. However, long-term culture has been shown alter primary properties. Additionally, early passage MSCs assumed represent situ, however, little research done support this. Here, we compared transcriptomic profiles murine freshly isolated from bone marrow those that had 10 days. We identified single extensively altered...

10.1038/s41598-024-63009-8 article EN cc-by Scientific Reports 2024-05-29
Coming Soon ...